HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Feinstein, EWG Gunning For Spring Senate Hearing On Cosmetics Bill

This article was originally published in The Rose Sheet

Executive Summary

During a March 1 press call, the Environmental Working Group highlighted findings from an 800-person survey indicating that 68% of men and women likely to vote this fall support increased government oversight of cosmetic chemicals. Senator Dianne Feinstein touted her proposed Personal Care Products Safety Act as the answer to consumer concerns, hopeful that a Senate committee hearing will be held in the spring.


Related Content

EWG’s Mary Kay Initiative For The PCPSA: Tactical Blitz Or Hail Mary?
FDA Seeks Info From Injured WEN Users, Docs As Investigation Continues
PCPSA's 'No Harm' Standard Would Set High Bar For FDA Ingredient Review
In Brief: CMA Bill Picks Up Democrat Backer; Avon Slashing Headcount; More
FDA Going Through Enforcement Toolkit To Address Bentonite Me Baby
Teen Study Promoting Switch To 'Free Of' Cosmetics Causes Usual Row
FDA Cosmetic Adverse Event Data Beg Question: Mandatory Reporting?
FDA Has Eye On 'Non-Traditional Preservative' Use, Updates Internal Guide
Feinstein Bill Lacks ‘Crucial’ National Uniformity Assurance – ICMAD
Sen. Feinstein’s Cosmetics Safety Bill Launches With GOP Cosponsor





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts